← Open Payments lookup

EMILY GEISE-SMITH: Open Payments

NPI 1538624978 · ELLICOTT CITY, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,023 in 41 payments from 13 companies in 2025. Trend: 2023 $900 · 2024 $859 · 2025 $1,023

Food & beverage: $1,023
CompanyPaymentsAmount
ABBVIE INC.13$246
Madrigal Pharmaceuticals5$226
Salix Pharmaceuticals, a division of Bausch Health US, LLC4$97
Gilead Sciences, Inc.4$85
Takeda Pharmaceuticals U.S.A., Inc.3$83
Ardelyx, Inc.3$82
Janssen Biotech, Inc.2$40
PFIZER INC.2$35
Regeneron Healthcare Solutions, Inc.1$30
Celltrion USA Inc.1$28

Products named: REZDIFFRA, SKYRIZI, XIFAXAN, ENTYVIO, RINVOQ, IBSRELA, TREMFYA, VELSIPITY.

Industry payments across MD — which companies pay providers there.